Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: A Randomized Clinical Trial.

ABSTRACT:

Importance

Reducing myopia progression can reduce the risk of associated ocular pathologies.

Objective

To evaluate whether spectacle lenses with higher lenslet asphericity have a higher myopia control efficacy throughout 2 years.

Design, setting, and participants

This double-masked randomized clinical trial was conducted between July 2018 and October 2020 at the Eye Hospital of Wenzhou Medical University in Wenzhou, China. Children aged 8 to 13 years with a cycloplegic spherical equivalent refraction (SER) of -0.75 D to -4.75 D and astigmatism with less than -1.50 D were recruited. A data and safety monitoring committee reviewed findings from a planned interim analysis in 2019.

Interventions

Participants were randomly assigned in a 1:1:1 ratio to receive specta

SUBMITTER: Bao J 

PROVIDER: S-EPMC8972151 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature